Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study.

@article{Cokkinos2006EfficacyOA,
  title={Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study.},
  author={Dennis Vassilios Cokkinos and George C Haralabopoulos and John B. Kostis and Pavlos K. Toutouzas},
  journal={European journal of heart failure},
  year={2006},
  volume={8 4},
  pages={428-32}
}
BACKGROUND It is not clear if long-term antithrombotic treatment has a beneficial effect on the incidence of thromboembolism in chronic heart failure (CHF). The HELAS study (Heart failure Long-term Antithrombotic Study) is a multicentre, randomised, double-blind, placebo-controlled trial to evaluate antithrombotic treatment in patients with CHF. METHODS 197HF patients (EF <35%) were enrolled. Patients with Ischaemic Heart Disease were randomised to receive either aspirin 325mg or warfarin… CONTINUE READING
44 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

Similar Papers

Loading similar papers…